SPRAVATO® Treatment
Esketamine, also known as-ketamine or S-ketamine, is the S enantiomer of ketamine, is a dissociative hallucinogen medication used as an antidepressant for treatment of depression.
About Spravato®
What is it?
SPRAVATO® is a prescription medicine, used along with an antidepressant taken by mouth to treat:
- Adults with treatment-resistant depression (TRD)
- Depressive symptoms in adults with major depressive disorder (MDD) with suicidal thoughts or actions
SPRAVATO® (esketamine) CIII nasal spray is the S-enantiomer of racemic ketamine. SPRAVATO® is an FDA-approved nasal spray for TRD and MDSI. Ketamine infusion has not been approved by the FDA to treat depression. There are no head-to-head studies comparing esketamine and ketamine infusion. Both SPRAVATO® and ketamine are Schedule III controlled substances under the U.S. Controlled Substances Act.
SPRAVATO® should be administered in conjunction with an oral antidepressant (AD).
The cost of SPRAVATO® depends on your insurance plan.
No, SPRAVATO® must be administered in a certified healthcare setting.
Get Started With Spravato®
If you’re interested in Spravato® or wondering if it may be right for you, please contact us! We’re ready to help you get started.
More About Spravato
Hear stories from real Spravato patients and learn about what you can expect from treatment.